Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
We will investigate the process of vitiligo induction and the influence of different commonly used cream treatments on this process. Studies comparing different treatments for vitiligo in the induction stage of the disease are still missing. The study hypothesis = cream treatment can stop actively spreading vitiligo lesions during the early induction stage of the disease.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| topical tacrolimus | Active Comparator |
| |
| topical pimecrolimus | Active Comparator |
| |
| local steroids | Active Comparator |
| |
| cold cream | Placebo Comparator |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| topical tacrolimus treatment | Drug | 4 applications (day 1,day 3, day 6 and day10) |
| |
| Measure | Description | Time Frame |
|---|---|---|
| percentage of skin pigmentation in the treated area | digital image analysis system for surface measurement | after 1 day, 10 days, 30 days and 60 days |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Nanny Van Geel, MD, PhD | University Hospital, Ghent | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University Hospital Ghent | Ghent | Belgium |
Not provided
| Label | URL |
|---|---|
| website University Hospital Ghent | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| topical pimecrolimus treatment |
| Drug |
4 applications (day 1, day 3, day 6 and day 10) |
|
| local mometasone furoate treatment | Drug | 4 applications (day 1, day 3, day 6 and day 10) |
|
| cold cream | Drug | 4 applications (day 1, day 3, day 6 and day 10) |
|
| ID | Term |
|---|---|
| D014820 | Vitiligo |
| ID | Term |
|---|---|
| D017496 | Hypopigmentation |
| D010859 | Pigmentation Disorders |
| D012871 | Skin Diseases |
| D017437 | Skin and Connective Tissue Diseases |
Not provided
Not provided